ÅëÁõ ÇÑ·©¿ä¹ý ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼ : Á¦Ç°º°, ¿ëµµº°, À¯Åë ä³Îº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
Cold Pain Therapy Market Size, Share & Trends Analysis Report By Product, By Application (Orthopedic Conditions, Post-operative Therapy, Sports Medicine), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå
:
1609981
¸®¼Ä¡»ç
:
Grand View Research, Inc.
¹ßÇàÀÏ
:
2024³â 11¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 100 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
ÅëÁõ ÇÑ·©¿ä¹ý ½ÃÀå ¼ºÀå°ú µ¿Çâ
Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼¿¡ µû¸£¸é, ¼¼°è ÅëÁõ ÇÑ·©¿ä¹ý ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 31¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025-2030³â±îÁö ¿¬Æò±Õ 4.0%ÀÇ ¼ºÀå·üÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. CDC´Â 2040³â±îÁö ¹Ì±¹¿¡¼ 18¼¼ ÀÌ»ó Àα¸ Áß ¾à 7,800¸¸ ¸íÀÌ °üÀý¿° Áø´ÜÀ» ¹ÞÀ» °ÍÀ¸·Î ÃßÁ¤Çϰí ÀÖÀ¸¸ç, Á¤Çü¿Ü°ú ÁúȯÀÇ À¯º´·ü Áõ°¡°¡ ½ÃÀåÀÇ ³ôÀº ¼ºÀå¼¼¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù.
±³Åë»ç°í¿Í ¿Ü»óÀÇ Áõ°¡´Â ½ÃÀåÀÇ °í¼ºÀåÀ» ÁÖµµÇϰí ÀÖÀ¸¸ç, WHO µ¥ÀÌÅÍ¿¡ µû¸£¸é ¸Å³â 1,000¸¸ ¸í¿¡ °¡±î¿î »ç¶÷µéÀÌ ±³Åë»ç°í·Î ºÎ»óÀ» À԰ųª ¸Ó¸®, °¡½¿, ÆÈ, ´Ù¸® ºÎ»óÀ» ÀÔ¾î Àå¾Ö¸¦ ÀÔ½À´Ï´Ù. µû¶ó¼ ±³Åë»ç°í°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÅëÁõ °ü¸®¸¦ À§ÇÑ Ä¡·á Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ½ºÆ÷Ã÷ ºÎ»óÀÇ Áõ°¡µµ ÀÌ·¯ÇÑ Á¦Ç° ¼ö¿ä Áõ°¡¿¡ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ½ºÆ÷Ã÷ ºÎ»óÀÇ °¡Àå ÈçÇÑ À¯ÇüÀº °üÀý Å»±¸, ±ÙÀ° ¿°Á ¹× ±äÀå, °üÀýÀ» ÁöÅÊÇÏ´Â ÀÎ´ë ¹× ÈûÁÙ ÆÄ¿, ôÃ߸¦ Æ÷ÇÔÇÑ »ÀÀÇ °ñÀýÀÔ´Ï´Ù.
³ë³âÃþÀº ½ÃÀåÀ» ÁÖµµÇÏ´Â Áß¿äÇÑ ´ë»ó Àα¸´Ù. µ¶Àϰú Áß±¹ °°Àº ±¹°¡´Â ³ëÀÎ Àα¸°¡ ¸¹½À´Ï´Ù. CDC¿¡ µû¸£¸é ¼ºÀÎ 4¸í Áß 1¸íÀÌ °ñ°üÀý¿°À» ¾Î°í ÀÖÀ¸¸ç, ÀÌ ¿äÀÎÀÌ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. µû¶ó¼ ³ëÀÎ Àα¸ÀÇ Áõ°¡´Â ³ÃÂòÁú Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÅëÁõ ÇÑ·©¿ä¹ý ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
- Å©¸², Á©, ½ºÇÁ·¹ÀÌ, ·Ñ¿Â µîÀÇ Á¦Ç°ÀÌ Àú·ÅÇÑ °¡°ÝÀ¸·Î ½±°Ô ±¸ÇÒ ¼ö Àֱ⠶§¹®¿¡ 2024³â ½ÃÀåÀº ½ÃÆÇ Á¦Ç°ÀÌ Áö¹èÀûÀ̾ú½À´Ï´Ù.
- ½ºÆ÷Ã÷ °ü·Ã ºÎ»óÀÇ Áõ°¡·Î ÀÎÇØ ½ºÆ÷Ã÷ ÀÇ·á ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È »ó´çÇÑ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
- ¼Ò¸Å¾à±¹Àº 2024³â Á¦Ç° Á¢±Ù¼º Çâ»óÀ¸·Î ÀÎÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ »ó´çÇÑ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
- ¸ðµç À¯Åë ä³Î Áß E-Commerce´Â ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
- ºÏ¹Ì´Â Á¤Çü¿Ü°ú ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ÀÌ Áö¿ªÀÇ ÁÖ¿ä ½ÃÀå ÁøÀÔ ±â¾÷ÀÇ Á¸Àç µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ 2018³â¿¡ ³Ã°£ ÅëÁõ Ä¡·á ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù.
- ¾Æ½Ã¾ÆÅÂÆò¾çÀº ³ëÀÎ Àα¸ Áõ°¡¿Í ÀÇ·á¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ ¿¹Ãø ±â°£ µ¿¾È ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.
- Á¤Çü¿Ü°ú ÁúȯÀº °ñ°üÀý¿°°ú °°Àº ´Ù¾çÇÑ ±Ù°ñ°Ý°è ¹× °üÀý ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ 2024³â 49.9%ÀÇ Á¡À¯À²À» Â÷ÁöÇÏ¸ç ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.
- ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À¸·Î´Â ¹ÙÀ̾µµ¸£ÇÁ, ºê·º, DJO ¿ùµå, ±¸±¤¾àǰ, Á¸½¼¾ØµåÁ¸½¼, ¿À½´¾Æ µîÀÌ ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ÅëÁõ ÇÑ·©¿ä¹ý ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§
- ½ÃÀå °èÅë Àü¸Á
- ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
- ºñÁî´Ï½º ȯ°æ ºÐ¼®
- »ê¾÷ ºÐ¼® - Porter's Five Forces ºÐ¼®
- PESTLE ºÐ¼®
Á¦4Àå ÅëÁõ ÇÑ·©¿ä¹ý ½ÃÀå : Á¦Ç° ºñÁî´Ï½º ºÐ¼®
- Á¦Ç° ½ÃÀå Á¡À¯À², 2024³â°ú 2030³â
- Á¦Ç° ºÎ¹® ´ë½Ãº¸µå
- ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, Á¦Ç°º°, 2018-2030³â
- ½ÃÆÇ Á¦Ç°
- ó¹æ Á¦Ç°
Á¦5Àå ÅëÁõ ÇÑ·©¿ä¹ý ½ÃÀå : ¿ëµµ ºñÁî´Ï½º ºÐ¼®
- ¿ëµµ ½ÃÀå Á¡À¯À², 2024³â°ú 2030³â
- ¿ëµµ ºÎ¹® ´ë½Ãº¸µå
- ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, ¿ëµµº°, 2018-2030³â
- Á¤Çü¿Ü°ú Áúȯ
- ¼ö¼úÈÄ ¿ä¹ý
- ½ºÆ÷Ã÷ ÀÇ·á
- ½É¸®Àû ¿Ü»ó ÈÄ ¿ä¹ý
Á¦6Àå ÅëÁõ ÇÑ·©¿ä¹ý ½ÃÀå : À¯Åë ä³Î ºñÁî´Ï½º ºÐ¼®
- À¯Åë ä³Î ½ÃÀå Á¡À¯À², 2024³â°ú 2030³â
- À¯Åë ä³Î ºÎ¹® ´ë½Ãº¸µå
- ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®, À¯Åë ä³Îº°, 2018-2030³â
- º´¿ø ¾à±¹
- ¼Ò¸Å ¾à±¹
- E-Commerce
Á¦7Àå ÅëÁõ ÇÑ·©¿ä¹ý ½ÃÀå : Á¦Ç°, ¿ëµµ, À¯Åë ä³Î, Áö¿ªº°, ÃßÁ¤¡¤µ¿Ç⠺м®
- Áö¿ªº° ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â°ú 2030³â
- Áö¿ªº° ½ÃÀå ´ë½Ãº¸µå
- ½ÃÀå ±Ô¸ð, ¿¹Ãø µ¿Ç⠺м®, 2018-2030³â
- ºÏ¹Ì
- ±¹°¡º°, 2018-2030³â
- ¹Ì±¹
- ij³ª´Ù
- ¸ß½ÃÄÚ
- À¯·´
- ±¹°¡º°, 2018-2030³â
- ¿µ±¹
- µ¶ÀÏ
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- ³ë¸£¿þÀÌ
- µ§¸¶Å©
- ½º¿þµ§
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ±¹°¡º°, 2018-2030³â
- ÀϺ»
- Áß±¹
- Àεµ
- Çѱ¹
- È£ÁÖ
- ű¹
- ¶óƾ¾Æ¸Þ¸®Ä«
- ±¹°¡º°, 2018-2030³â
- ºê¶óÁú
- ¾Æ¸£ÇîÆ¼³ª
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ±¹°¡º°, 2018-2030³â
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®
- Äí¿þÀÌÆ®
Á¦8Àå °æÀï ±¸µµ
- Âü¿©ÀÚ °³¿ä
- ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Ç ºÐ¼®
- ±â¾÷ ºÐ·ù
- Àü·« ¸ÅÇÎ
- ±â¾÷ °³¿ä/»óÀå ±â¾÷
- Beiersdorf
- Breg, Inc.
- DJO Global(Enovis Corporation)
- Johnson & Johnson Services, Inc.
- Ossur
- Performance Health
- ROHTO Pharmaceutical Co.,Ltd.
- Romsons Group of Industries
- Medline Industries, LP.
- Unexo Life Sciences Pvt. Ltd.
ksm
¿µ¹® ¸ñÂ÷
Cold Pain Therapy Market Growth & Trends:
The global cold pain therapy market size is estimated to reach USD 3.12 billion by 2030, expanding at a CAGR of 4.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising incidence of orthopedic diseases has led to high growth of the market. CDC estimated that nearly 78 million people in the U.S., aged 18 years or above, are expected to be diagnosed with arthritis by 2040.
Rising number of road accidents and traumatic injuries is leading to a high growth of the market. According to WHO data, every year nearly 10 million people suffer injuries in road accidents or incur a disability as a result of injuries in head, chest, arms, and legs. Thus, with the increasing number of road accidents, the demand for therapy products for pain management is rising. Increasing number of sports injuries also play a pivotal role in the rising demand for these products. The most common types of sport injuries are dislocated joints, muscle sprains & strains, tear of ligaments & tendons that hold the joints together, and fractured bones, including the vertebrae.
Geriatric population is a significant target population driving the market. Countries such as Germany and China have high geriatric population base. This factor is contributing to market growth. According to CDC, 1 in every 4 adults are affected by osteoarthritis. Thus, rising geriatric population is expected to increase the demand for cold pain therapy products.
Cold Pain Therapy Market Report Highlights:
- OTC products dominated the market in 2024 due to affordability and easy availability of products such as creams, gels, sprays, and roll-ons
- The sports medicine segment is expected to witness a significant growth during the forecast period due to increasing number of sport-related injuries
- Retail pharmacies accounted for a considerable revenue share in 2024, owing to increase in their demand due to easy availability of products
- Among all distribution channels, e-commerce is expected to grow at the highest CAGR during the forecast period, owing to lucrative offers and discounts available online
- North America dominated the cold pain therapy market in 2018 due to factors such as an increase in the prevalence of orthopedic disorders and presence of key market players in the region
- Asia Pacific is likely to grow at a high rate over the forecast period due to rising geriatric population, coupled with growing healthcare awareness in the region
- Orthopedic conditions led the market and accounted for a share of 49.9% in 2024 owing to rising prevalence of various musculoskeletal and joint disorders, such as osteoarthritis
- Some of the major companies in the market are Beiersdorf; Breg, Inc.; DJO Global; Hisamitsu Pharmaceutical Co., Inc.; Johnson & Johnson; and Ossur Corporate.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. Distribution Channel
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Cold Pain Therapy Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
- 3.3.1.1. Supplier Power
- 3.3.1.2. Buyer Power
- 3.3.1.3. Substitution Threat
- 3.3.1.4. Threat of New Entrants
- 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis
Chapter 4. Cold Pain Therapy Market: Product Business Analysis
- 4.1. Product Market Share, 2024 & 2030
- 4.2. Product Segment Dashboard
- 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. OTC Products
- 4.4.1. OTC Products Market, 2018 - 2030 (USD Million)
- 4.4.2. Gels, Ointments & Creams
- 4.4.2.1. Gels, Ointments & Creams Market, 2018 - 2030 (USD Million)
- 4.4.3. Sprays & Foams
- 4.4.3.1. Sprays & Foams Market, 2018 - 2030 (USD Million)
- 4.4.4. Patches
- 4.4.4.1. Patches Market, 2018 - 2030 (USD Million)
- 4.4.5. Roll-ons
- 4.4.5.1. Roll-ons Market, 2018 - 2030 (USD Million)
- 4.4.6. Cold Packs
- 4.4.6.1. Cold Packs Market, 2018 - 2030 (USD Million)
- 4.4.7. Others
- 4.4.7.1. Others Market, 2018 - 2030 (USD Million)
- 4.5. Prescription Products
- 4.5.1. Prescription Products Market, 2018 - 2030 (USD Million)
- 4.5.2. Motorized Devices
- 4.5.2.1. Motorized Devices Market, 2018 - 2030 (USD Million)
- 4.5.3. Non-motorized Devices
- 4.5.3.1. Non-motorized Devices Market, 2018 - 2030 (USD Million)
Chapter 5. Cold Pain Therapy Market: Application Business Analysis
- 5.1. Application Market Share, 2024 & 2030
- 5.2. Application Segment Dashboard
- 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 5.4. Orthopedic Conditions
- 5.4.1. Orthopedic Conditions Market, 2018 - 2030 (USD Million)
- 5.5. Post-operative Therapy
- 5.5.1. Post-operative Therapy Market, 2018 - 2030 (USD Million)
- 5.6. Sports Medicine
- 5.6.1. Sports Medicine Market, 2018 - 2030 (USD Million)
- 5.7. Post-trauma Therapy
- 5.7.1. Post-trauma Therapy Market, 2018 - 2030 (USD Million)
Chapter 6. Cold Pain Therapy Market: Distribution Channel Business Analysis
- 6.1. Distribution Channel Market Share, 2024 & 2030
- 6.2. Distribution Channel Segment Dashboard
- 6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
- 6.4. Hospital Pharmacies
- 6.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
- 6.5. Retail Pharmacies
- 6.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
- 6.6. E-commerce
- 6.6.1. E-commerce Market, 2018 - 2030 (USD Million)
Chapter 7. Cold Pain Therapy Market: Regional Estimates & Trend Analysis by Product, Application, and Distribution Channel
- 7.1. Regional Market Share Analysis, 2024 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 7.4. North America
- 7.4.1. North America Cold Pain Therapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.4.2. U.S.
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Regulatory Framework
- 7.4.2.3. Competitive Insights
- 7.4.2.4. U.S. Cold Pain Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Canada
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Regulatory Framework
- 7.4.3.3. Competitive Insights
- 7.4.3.4. Canada Cold Pain Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. Mexico
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Regulatory Framework
- 7.4.4.3. Competitive Insights
- 7.4.4.4. Mexico Cold Pain Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5. Europe
- 7.5.1. Europe Cold Pain Therapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.5.2. UK
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Regulatory Framework
- 7.5.2.3. Competitive Insights
- 7.5.2.4. UK Cold Pain Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Germany
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Regulatory Framework
- 7.5.3.3. Competitive Insights
- 7.5.3.4. Germany Cold Pain Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. France
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Regulatory Framework
- 7.5.4.3. Competitive Insights
- 7.5.4.4. France Cold Pain Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.5. Italy
- 7.5.5.1. Key Country Dynamics
- 7.5.5.2. Regulatory Framework
- 7.5.5.3. Competitive Insights
- 7.5.5.4. Italy Cold Pain Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.6. Spain
- 7.5.6.1. Key Country Dynamics
- 7.5.6.2. Regulatory Framework
- 7.5.6.3. Competitive Insights
- 7.5.6.4. Spain Cold Pain Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.7. Norway
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Regulatory Framework
- 7.5.7.3. Competitive Insights
- 7.5.7.4. Norway Cold Pain Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.8. Denmark
- 7.5.8.1. Key Country Dynamics
- 7.5.8.2. Regulatory Framework
- 7.5.8.3. Competitive Insights
- 7.5.8.4. Denmark Cold Pain Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.9. Sweden
- 7.5.9.1. Key Country Dynamics
- 7.5.9.2. Regulatory Framework
- 7.5.9.3. Competitive Insights
- 7.5.9.4. Sweden Cold Pain Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6. Asia Pacific
- 7.6.1. Asia Pacific Cold Pain Therapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.6.2. Japan
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Regulatory Framework
- 7.6.2.3. Competitive Insights
- 7.6.2.4. Japan Cold Pain Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. China
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Regulatory Framework
- 7.6.3.3. Competitive Insights
- 7.6.3.4. China Cold Pain Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. India
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Regulatory Framework
- 7.6.4.3. Competitive Insights
- 7.6.4.4. India Cold Pain Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. South Korea
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Regulatory Framework
- 7.6.5.3. Competitive Insights
- 7.6.5.4. South Korea Cold Pain Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.6. Australia
- 7.6.6.1. Key Country Dynamics
- 7.6.6.2. Regulatory Framework
- 7.6.6.3. Competitive Insights
- 7.6.6.4. Australia Cold Pain Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.7. Thailand
- 7.6.7.1. Key Country Dynamics
- 7.6.7.2. Regulatory Framework
- 7.6.7.3. Competitive Insights
- 7.6.7.4. Thailand Cold Pain Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.7. Latin America
- 7.7.1. Latin America Cold Pain Therapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.7.2. Brazil
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Regulatory Framework
- 7.7.2.3. Competitive Insights
- 7.7.2.4. Brazil Cold Pain Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.7.3. Argentina
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Regulatory Framework
- 7.7.3.3. Competitive Insights
- 7.7.3.4. Argentina Cold Pain Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.8. MEA
- 7.8.1. MEA Cold Pain Therapy Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.8.2. South Africa
- 7.8.2.1. Key Country Dynamics
- 7.8.2.2. Regulatory Framework
- 7.8.2.3. Competitive Insights
- 7.8.2.4. South Africa Cold Pain Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.8.3. Saudi Arabia
- 7.8.3.1. Key Country Dynamics
- 7.8.3.2. Regulatory Framework
- 7.8.3.3. Competitive Insights
- 7.8.3.4. Saudi Arabia Cold Pain Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.8.4. UAE
- 7.8.4.1. Key Country Dynamics
- 7.8.4.2. Regulatory Framework
- 7.8.4.3. Competitive Insights
- 7.8.4.4. UAE Cold Pain Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.8.5. Kuwait
- 7.8.5.1. Key Country Dynamics
- 7.8.5.2. Regulatory Framework
- 7.8.5.3. Competitive Insights
- 7.8.5.4. Kuwait Cold Pain Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Participant Overview
- 8.2. Company Market Position Analysis
- 8.3. Company Categorization
- 8.4. Strategy Mapping
- 8.5. Company Profiles/Listing
- 8.5.1. Beiersdorf
- 8.5.1.1. Overview
- 8.5.1.2. Financial Performance
- 8.5.1.3. Product Benchmarking
- 8.5.1.4. Strategic Initiatives
- 8.5.2. Breg, Inc.
- 8.5.2.1. Overview
- 8.5.2.2. Financial Performance
- 8.5.2.3. Product Benchmarking
- 8.5.2.4. Strategic Initiatives
- 8.5.3. DJO Global (Enovis Corporation)
- 8.5.3.1. Overview
- 8.5.3.2. Financial Performance
- 8.5.3.3. Product Benchmarking
- 8.5.3.4. Strategic Initiatives
- 8.5.4. Johnson & Johnson Services, Inc.
- 8.5.4.1. Overview
- 8.5.4.2. Financial Performance
- 8.5.4.3. Product Benchmarking
- 8.5.4.4. Strategic Initiatives
- 8.5.5. Ossur
- 8.5.5.1. Overview
- 8.5.5.2. Financial Performance
- 8.5.5.3. Product Benchmarking
- 8.5.5.4. Strategic Initiatives
- 8.5.6. Performance Health
- 8.5.6.1. Overview
- 8.5.6.2. Financial Performance
- 8.5.6.3. Product Benchmarking
- 8.5.6.4. Strategic Initiatives
- 8.5.7. ROHTO Pharmaceutical Co.,Ltd.
- 8.5.7.1. Overview
- 8.5.7.2. Financial Performance
- 8.5.7.3. Product Benchmarking
- 8.5.7.4. Strategic Initiatives
- 8.5.8. Romsons Group of Industries
- 8.5.8.1. Overview
- 8.5.8.2. Financial Performance
- 8.5.8.3. Product Benchmarking
- 8.5.8.4. Strategic Initiatives
- 8.5.9. Medline Industries, LP.
- 8.5.9.1. Overview
- 8.5.9.2. Financial Performance
- 8.5.9.3. Product Benchmarking
- 8.5.9.4. Strategic Initiatives
- 8.5.10. Unexo Life Sciences Pvt. Ltd.
- 8.5.10.1. Overview
- 8.5.10.2. Financial Performance
- 8.5.10.3. Product Benchmarking
- 8.5.10.4. Strategic Initiatives
°ü·ÃÀÚ·á